A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study

Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison, Hania Al‐Hallaq, Philip C. Hoffman, Michael J. Jelinek, Aditya Juloori, J.M. Melotek, Septimiu Murgu, J. Partouche, Everett E. Vokes, Ralph R. Weichselbaum, Sean P. Pitroda, Jyoti D. Patel, Steven J. Chmura